Elidel skin cancer
FDA links eczema drugs to possibility of cancer
WASHINGTON (AP) -- The Food and Drug Administration issued an advisory to doctors Thursday urging caution in prescribing two drugs for eczema because of the possibility of cancer.
The drugs Elidel and Protopic will receive new label warnings pointing out that an increased risk of cancer may be associated with their use, the agency said.
Elidel and Protopic are applied to the skin to control eczema by suppressing the immune system.
But animal tests have shown an increase in cancer associated with the drugs, and a small number of cancers have been reported in children and adults treated with the drugs, FDA said in its advisory.
Copyright C 2005 Deseret News Publishing Co.
Provided by ProQuest Information and Learning Company. All rights Reserved.
Cancer
Canine skin cancer